Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial

NCT07699107 is registered in ClinicalTrials.gov with Nisha Acharya as lead sponsor.

NCT NCT07699107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07699107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
Lead sponsor
Nisha Acharya
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
November 30, 2030
Enrollment
160 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis associated uveitis, uveitis, anterior